V
Velarion™Intelligence
Sign InFree TrialBook a Walkthrough
MedTech & Diagnostics

LeMaitre Vascular Executive Compensation (FY25)

LMAT · Executive and director compensation, fiscal 2023 to 2025
Data as of September 7, 2026Latest filing (8-K): June 5, 2026
273 figures on this page: 271 cited to the filing that reported them, 2 calculated from figures it prints. See the citations
George LeMaitre was paid $3,780,990 in total compensation as Chairman and Chief Executive Officer for fiscal 2025, and compared with the $3,235,558 reported for fiscal 2024, LeMaitre's total was 16.9% higher, while for fiscal 2025, the company reported a chief executive pay ratio of 43:1, against median employee compensation of $88,782. For fiscal 2025, shareholders backed the say-on-pay proposal with 96.0% of votes cast for or against in favor at the meeting held June 2, 2026. The fiscal 2025 disclosure covers 5 named executive officers.
Chief executive, fiscal 2025
◇
George LeMaitre
Latest say-on-pay support
=
June 2, 2026
Chief executive pay ratio
◇
To the median employee
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive total compensation — George LeMaitre: $3,235,558 → $3,780,990 (16.9% higher)
Say-on-pay support: 95.4% → 96.0% (0.6 points higher)

Frequently asked questions

Answers drawn from the data on this page.
Who is LeMaitre Vascular's chief executive and what were they paid?
George LeMaitre was paid $3,780,990 in total compensation as Chairman and Chief Executive Officer for fiscal 2025. Compared with the $3,235,558 reported for fiscal 2024, LeMaitre's total was 16.9% higher.
What was LeMaitre Vascular's say-on-pay result?
For fiscal 2025, shareholders backed the say-on-pay proposal with 96.0% of votes cast for or against in favor at the meeting held June 2, 2026.
What is LeMaitre Vascular's chief executive pay ratio?
For fiscal 2025, the company reported a chief executive pay ratio of 43:1, against median employee compensation of $88,782.

Executive compensation

Every element reported for each named executive officer, by fiscal year.
Fiscal 2023
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
George LeMaitre
Chairman and Chief Executive Officer
◇—◇◇◇—◇◇
David Roberts
President
◇—◇◇◇—◇◇
Joseph Pellegrino
Former Chief Financial Officer
◇◇◇◇◇——◇
Trent Kamke
Senior Vice President, Operations
◇◇◇◇◇—◇— not reconciled
Fiscal 2024
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
George LeMaitre
Chairman and Chief Executive Officer
◇—◇◇◇—◇◇
Joseph Pellegrino
Former Chief Financial Officer
◇—◇◇◇——◇
David Roberts
President
◇◇◇◇◇—◇◇
Trent Kamke
Senior Vice President, Operations
◇◇◇◇◇—◇— not reconciled
Fiscal 2025
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
George LeMaitre
Chairman and Chief Executive Officer
◇—◇◇◇—◇◇
David Roberts
President
◇◇◇◇◇—◇◇
Dorian LeBlanc
Chief Financial Officer
◇◇◇◇◇—◇◇
Trent Kamke
Senior Vice President, Operations
◇◇◇◇◇—◇◇
Joseph Pellegrino
Former Chief Financial Officer
Departed during or after this year
◇◇————◇◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.

Equity awards granted

Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
OfficerAwardGrant dateThreshold unitsTarget unitsUnits grantedMaximum unitsExercise priceGrant date fair value
David B. RobertsPSU◇◇◇—◇—◇
David B. RobertsOPTION◇——◇—◇◇
Dorian P. LeBlancPSU◇◇◇—◇—◇
Dorian P. LeBlancOPTION◇——◇—◇◇
George W. LeMaitrePSU◇◇◇—◇—◇
George W. LeMaitreOPTION◇——◇—◇◇
Joseph P. Pellegrino JrOPTION◇——◇—◇◇
Joseph P. Pellegrino JrPSU◇◇◇—◇—◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.

Outstanding awards

Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
OfficerAwardUnvested unitsMarket value of unvested unitsExercise priceExpires
David RobertsOption◇—◇—
RSU◇◇——
PSU◇◇——
Option◇—◇—
Option◇—◇—
RSU◇◇——
Option◇—◇—
Option◇—◇—
RSU◇◇——
PSU◇◇——
RSU◇◇——
PSU◇◇——
PSU◇◇——
Joseph PellegrinoPSU◇◇——
Option◇—◇—
RSU◇◇——
RSU◇◇——
PSU◇◇——
PSU◇◇——
Option◇—◇—
Option◇—◇—
RSU◇◇——
RSU◇◇——
PSU◇◇——
Option◇—◇—
Trent KamkePSU◇◇——
RSU◇◇——
PSU◇◇——
RSU◇◇——
PSU◇◇——
Option◇—◇—
Option◇—◇—
RSU◇◇——
RSU◇◇——
Option◇—◇—
PSU◇◇——
Option◇—◇—
George LeMaitrePSU◇◇——
Option◇—◇—
Option◇—◇—
Option◇—◇—
Option◇—◇—
RSU◇◇——
PSU◇◇——
RSU◇◇——
Option◇—◇—
Option◇—◇—
Option◇—◇—
Option◇—◇—
PSU◇◇——
RSU◇◇——
RSU◇◇——
PSU◇◇——
Dorian LeBlancOption◇—◇—
Option◇—◇—
RSU◇◇——
PSU◇◇——
RSU◇◇——
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director compensation

What each non-employee director was paid.
Fiscal 2025
DirectorFees earned in cashStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Lawrence J. Jasinski
◇◇◇———◇
John J. O'Connor
◇◇◇———◇
John A. Roush
◇◇◇———◇
Bridget A. Ross
◇◇◇———◇
Martha Shadan
◇◇◇———◇
Joseph P. Pellegrino, Jr
◇◇◇———◇
George W. LeMaitre served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director fee schedule

The standing retainers and premiums the board pays, as published.
Board equity retainer◇
Board chair premium◇
Audit committee chair◇
Audit committee member◇
Compensation committee chair◇
Compensation committee member◇
Nominating and governance member◇

Disclosed peer group

The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.

Say-on-pay history

Shareholder support for the compensation program, by year.
YearMeetingSupportVotes forVotes againstAbstentions
2025June 2, 2026=◇◇◇
2024June 2, 2025=◇◇◇

Chief executive pay ratio

As calculated and reported by the company.
Ratio
◇
Median employee compensation
◇
Chief executive total compensation
◇
Email me this page as a cited PDF
The same figures, the same citations, formatted to hand to a committee. Nothing is added that is not on this page.
Your address is used for this and nothing else. Unsubscribe in one click.
Tell me when LeMaitre Vascular files
You get a note when this company’s compensation data changes.
Your address is used for this and nothing else. Unsubscribe in one click.

What this page does not include

Everything above is a fact LeMaitre Vascular disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500
Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $1,200
Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion Intelligence
Adviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Enquire about access
Multiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion Intelligence
Join the list for a Velarion Pro seat
Full platform access for one person: every industry we cover, peer positioning, and the written analysis. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.
Join the list for Peer Group Review
Whether LeMaitre Vascular's disclosed peer group is defensible, who names LeMaitre Vascular back in their own benchmarking group, and how pay tracks performance across it. This is the analysis a compensation consultant delivers on the group above. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.

Citations

Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
273 figures on this page: 271 cited to the filing that reported them, 2 calculated from figures it prints.
271 cited to the filing
2 calculated from the filing

Documents cited

  1. 0001193125-26-257978
    Item 5.07 Submission of Matters to a Vote of Security Holders
  2. 0001193125-26-153877
    2025 DIRECTOR COMPENSATION · DIRECTOR COMPENSATION · Grants of Plan-Based Awards · Outstanding Equity Awards as of December 31, 2025 · and 2 more sections
  3. 0001437749-25-019314
    Item 5.07 Submission of Matters to a Vote of Security Holders
  4. 0001437749-25-012238
    Summary Compensation Table
  5. 0001437749-24-012147
    Summary Compensation Table
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “LeMaitre Vascular executive compensation, FY2023–FY2025.” https://intel.velarion.ai/comp/LMAT (accessed 2026).
Short form: data: Velarion
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about LeMaitre Vascular and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Setup guide and the full list of questions it answers

MedTech & Diagnostics rankings

Chief executive pay — MedTech & DiagnosticsCEO pay ratio — MedTech & DiagnosticsSay-on-pay support — MedTech & Diagnostics

Terms on this page

Say-on-Pay VoteCEO Pay RatioMedian Employee CompensationAll companies
Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
  author = {{Velarion Company Intelligence}},
  title = {Velarion database: executive and board compensation data},
  year = {2026},
  version = {2026Q3},
  doi = {10.5281/zenodo.22283854},
  publisher = {Zenodo},
  url = {https://doi.org/10.5281/zenodo.22283854}
}
For informational purposes only. Not investment, legal, or compensation advice.  The Pay Desk · Methodology · Terms · Privacy